DKSC Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
DKSC FAQ
What was Dakshidin Corporation Inc’s price range in the past 12 months?
Currently, no data Available
What is Dakshidin Corporation Inc’s market cap?
Dakshidin Corporation Inc’s market cap is $2.00M.
When is Dakshidin Corporation Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Dakshidin Corporation Inc’s earnings last quarter?
Currently, no data Available
Is Dakshidin Corporation Inc overvalued?
According to Wall Street analysts Dakshidin Corporation Inc’s price is currently Overvalued.
Does Dakshidin Corporation Inc pay dividends?
Dakshidin Corporation Inc does not currently pay dividends.
What is Dakshidin Corporation Inc’s EPS estimate?
Dakshidin Corporation Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Dakshidin Corporation Inc have?
Dakshidin Corporation Inc has 5,000,000,000 shares outstanding.
What happened to Dakshidin Corporation Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Dakshidin Corporation Inc?
Currently, no hedge funds are holding shares in DKSC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Dakshidin Corporation Inc
Dakshidin Corporation, Inc., through its subsidiaries, operates as a CBD/cannabis-based medical product company. It cultivates cannabis; and operates an online sales portal for CBD products. The company also manages distribution channel programs in the retail distribution, reselling, and direct sales market segments. Dakshidin Corporation, Inc. was formerly known as Avrada, Inc. and changed its name to Dakshidin Corporation, Inc. in February 2007. The company is based in Miami, Florida with additional offices in Las Vegas, Nevada.
Scinai Immunotherapeutics
―
Aditxt
―
MSP Recovery
―
CERo Therapeutics Holdings
―
CDT Equity
―
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors